Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | White Papers
Search Refinements

Contract Research White Papers

View white papers from other Pharmaceutical sectors:
46-60 of 165 results
Product Brochure: Bacteria Welcome
| By Eppendorf
BioBLU® f – Single-use vessels that meet microbial demands.
Contract Research & Services > Contract Research > White Papers
Product Brochure: Extra Versatile
| By Eppendorf
New Brunswick’s BioFlo®/CelliGen® 115 Autoclavable Fermentor and Bioreactor handles a wide variety of cells to meet your every need.
Contract Research & Services > Contract Research > White Papers
Product Brochure: When Less is More
| By Eppendorf
New Brunswick’s CelliGen® BLU Single-Use Bioreactor System.
Contract Research & Services > Contract Research > White Papers
Product Brochure: Customizable Control
| By Eppendorf
New Brunswick™ BioFlo® 510 benchtop SIP fermentation systems.
Contract Research & Services > Contract Research > White Papers
Product Brochure: Compact Mobility
| By Eppendorf
New Brunswick™ BioFlo® 610 mobile SIP fermentation systems.
Contract Research & Services > Contract Research > White Papers
Product Brochure: Scale-Up Seamlessly
| By Eppendorf
New Brunswick™ BioFlo® Pro pilot to production SIP fermentation systems.
Contract Research & Services > Contract Research > White Papers
Seamless
| By Eppendorf
New Brunswick™ BioCommand® Software for Fermentation & Cell Culture
Contract Research & Services > Contract Research > White Papers
Open Interface
| By Eppendorf
DASware® migrate: Manage your bioprocess data with DASGIP®.
Contract Research & Services > Contract Research > White Papers
Dependable Design
| By Eppendorf
New Brunswick™ CelliGen® Pro pilot to production SIP bioreactor systems.
Contract Research & Services > Contract Research > White Papers
System Flexibility
| By Eppendorf
New Brunswick™ CelliGen® 510 benchtop SIP bioreactor systems.
Contract Research & Services > Contract Research > White Papers
Controlled Cultivation of Stem Cells – Factors to Consider When Thinking of Scale-Up
| By Eppendorf
Great hopes and expectations are linked to stem cells as a tool for drug discovery and to stem cell-derived products in therapeutic applications. Though several products have made it to commercial stage, most of the research is still performed in small scales using simple cultivation systems such as spinner flasks or T-flasks.
Contract Research & Services > Contract Research > White Papers
The Value of Biobetters
| By PRA Health Sciences
The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biologics are expected to account for approximately 17% of total global spending on medicines by 2016, and reach an overall market value of $200 billion to $210 billion in 2016, up from $157 billion in 2011.Seven of the top 10 global medicines by spending will be a biologic within the next 5 years.
Contract Research & Services > Contract Research > White Papers
Global Biosimilar Development
| By PRA Health Sciences
Many different terms are used in different parts of the world to describe “biosimilar products.” It is important to understand and differentiate true biosimilars from others because of the potential concern for patient safety and efficacy, and the misconceptions that can arise from misleading published reports.
Contract Research & Services > Contract Research > White Papers
Global Capabilities in Central Nervous System Research
| By PRA Health Sciences
PRA Health Sciences’ (PRA) Early Development Services (EDS) group has a long-standing track record of early clinical development work in various CNS indications through our global clinical facilities.
Contract Research & Services > Contract Research > White Papers
46-60 of 165 results